Get the app
US › Healthcare

Hyperfine Inc (HYPR)

US · Healthcare · Medical Devices

$0.76-3.21%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$3.9M
Revenue YoY
+44.8%
Net profit
$-9.3M
EPS
$-0.09
EPS estimate
$-0.09
Net margin
-238.2%

EPS came in at -0.09 against a street estimate of -0.09 — a beat of 0.0%.

Key statistics

Market cap
$90.3M
Forward P/E
0.0
P/B
2.32
Book value
$0.35
EPS (TTM)
$-0.37
52-week high
$1.94
52-week low
$0.75
50-day MA
$0.86
200-day MA
$1.15
Beta
1.46

Analyst view

Analysts rate Hyperfine Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $2.03.

Shareholding

Insiders
4.44%
Institutions
22.49%

Largest institutional holders

FundStake
BlackRock Inc4.41%
Vanguard Capital Management, LLC3.19%
Geode Capital Management, LLC1.85%
Fosun International Ltd1.64%
Catalio Capital Management, LP1.24%
State Street Corp0.96%
Renaissance Technologies Corp0.89%
Alphabet Inc0.85%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Hyperfine Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-18.